Abstract
A randomized trial is reported which evaluates the effect of early diagnostic splenectomy on the prognosis of patients with Hodgkin's disease (HD) and uncertain prognosis. This was started in January 1973 and concluded in April 1979. Sixty-seven patients were entered in the study and 31 were randomized for splenectomy. All patients except 2 received total nodal irradiation, excluding the splenic and hepatic areas. After 40 months' observation there was no difference between the groups in respect of survival and the number of recurrences. However, relapses occurred earlier in the splenectomized patients. Pneumococcal septicaemia was recorded in 2 splenectomized patients. It is concluded that prognosis is not improved by diagnostic splenectomy in HD patients with uncertain prognosis and treated with total nodal irradiation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Askergren, J., Björkholm, M., Holm, G. et al. Prognostic effect of early diagnostic splenectomy in Hodgkin's disease: a randomized trial. Br J Cancer 42, 284–291 (1980). https://doi.org/10.1038/bjc.1980.228
Issue Date:
DOI: https://doi.org/10.1038/bjc.1980.228
This article is cited by
-
Clinical and laboratory findings in untreated patients with Hodgkin’s disease with special reference to age
Medical Oncology and Tumor Pharmacotherapy (1984)
